Review article: The association of diet with onset and relapse in patients with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 10, 2013, Pages 1172-1187

  Spooren, C E G M ^a   Pierik, M J ^a   Zeegers, M P ^a,b   Feskens, E J M ^c   Masclee, A A M ^a   Jonkers, D M A E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

UNSATURATED FATTY ACID;

ADAPTIVE IMMUNITY; BREAD; CACAO; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARBONATED BEVERAGE; CEREAL; CROHN DISEASE; DIET; DIETARY FIBER; DISEASE ASSOCIATION; DISEASE EXACERBATION; EATING HABIT; ENVIRONMENTAL FACTOR; FAT INTAKE; FRUIT; HUMAN; IMMUNE DYSREGULATION; INCIDENCE; INNATE IMMUNITY; INTESTINE FLORA; MIGRATION; ONSET AGE; PRIORITY JOURNAL; PROTEIN INTAKE; RECURRENT DISEASE; RELAPSE; REVIEW; SUGAR INTAKE; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; VEGETABLE;

COLITIS, ULCERATIVE; CROHN DISEASE; DIET; ENERGY INTAKE; FOOD HABITS; HUMANS; RECURRENCE; RESEARCH DESIGN; RISK;

EID: 84885959791     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12501     Document Type: Review

References (79)

1. Xavier RJ, Podolsky DK,. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-34.
2. Russel MG,. Changes in the incidence of inflammatory bowel disease: what does it mean? Eur J Intern Med 2000; 11: 191-6.
3. Lakatos L, Kiss LS, David G, et al,. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011; 17: 2558-65.
4. Zallot C, Quilliot D, Chevaux JB, et al,. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis 2013; 19: 66-72.
5. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK,. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008; 103: 3167-82.
6. Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K,. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 2007; 102: 1077-83.
7. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF,. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992; 33: 687-93.
8. Walker DG, Williams HR, Kane SP, et al,. Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK. Am J Gastroenterol 2011; 106: 1281-9.
9. Li X, Sundquist J, Hemminki K, Sundquist K,. Risk of inflammatory bowel disease in first- and second-generation immigrants in Sweden: a nationwide follow-up study. Inflamm Bowel Dis 2011; 17: 1784-91.
10. Goh K, Xiao SD,. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis 2009; 10: 1-6.
11. Shoda R, Matsueda K, Yamato S, Umeda N,. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63: 741-5.
12. Hou JK, Abraham B, El-Serag H,. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011; 106: 563-73.
13. Gentschew L, Ferguson LR,. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res 2012; 56: 524-35.
14. Riordan AM, Ruxton CH, Hunter JO,. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998; 52: 229-38.
15. Chapman-Kiddell CA, Davies PS, Gillen L, Radford-Smith GL,. Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis 2010; 16: 137-51.
16. Andersen V, Olsen A, Carbonnel F, Tjonneland A, Vogel U,. Diet and risk of inflammatory bowel disease. Dig Liver Dis 2012; 44: 185-94.
17. Talley NJ, Abreu MT, Achkar JP, et al,. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 2011; 106 (Suppl 1): S2-25.
18. Sokol H, Seksik P, Furet JP, et al,. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009; 15: 1183-9.
19. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y,. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008; 14: 147-61.
20. Wu GD, Chen J, Hoffmann C, et al,. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-8.
21. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF,. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006; 101: 993-1002.
22. Bianchi Porro G, Panza E,. Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed) 1985; 291: 971-2.
23. Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. Dietary and other risk factors of ulcerative colitis. A case-control study in Japan. J Clin Gastroenterol 1994; 19: 166-71.
24. Gilat T, Hacohen D, Lilos P, Langman MJ,. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987; 22: 1009-24.
25. Graham WB, Torrance B,. Br Med J (Clin Res Ed) 1978; 2: 768.
26. Halfvarson J, Jess T, Magnuson A, et al,. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006; 12: 925-33.
27. Jakobsen C, Paerregaard A, Munkholm P, Wewer V,. Environmental factors and risk of developing paediatric inflammatory bowel disease-A population based study 2007-2009. J Crohns Colitis 2013; 7: 79-88.
28. James AH,. Breakfast and Crohn's disease. Br Med J 1977; 1: 943-5.
29. Jarnerot G, Jarnmark I, Nilsson K,. Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 1983; 18: 999-1002.
30. Maconi G, Ardizzone S, Cucino C, Bezzio C, Russo AG, Bianchi Porro G,. Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study. World J Gastroenterol 2010; 16: 4297-304.
31. Martini GA, Brandes JW,. Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochenschr 1976; 54: 367-71.
32. Mayberry JF, Rhodes J, Allan R, et al,. Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 1981; 26: 444-8.
33. Octoratou M, Merikas E, Malgarinos G, Stanciu C, Triantafillidis JK,. A prospective study of pre-illness diet in newly diagnosed patients with Crohn's disease. Rev Med Chir Soc Med Nat Iasi 2012; 116: 40-9.
34. Pugazhendhi S, Sahu MK, Subramanian V, Pulimood A, Ramakrishna BS,. Environmental factors associated with Crohn's disease in India. Indian J Gastroenterol 2011; 30: 264-9.
35. Rawcliffe PM, Truelove SC,. Breakfast and Crohn's disease-I. Br Med J 1978; 2: 539-40.
36. Russel MG, Engels LG, Muris JW, et al,. Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998; 10: 243-9.
37. Spehlmann ME, Begun AZ, Saroglou E, et al,. Risk factors in German twins with inflammatory bowel disease: results of a questionnaire-based survey. J Crohns Colitis 2012; 6: 29-42.
38. Van Kruiningen HJ, Joossens M, Vermeire S, et al,. Environmental factors in familial Crohn's disease in Belgium. Inflamm Bowel Dis 2005; 11: 360-5.
39. D'Souza S, Levy E, Mack D, et al,. Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis 2008; 14: 367-73.
40. Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrugger RW, Brummer RJ,. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000; 95: 1008-13.
41. Hart AR, Luben R, Olsen A, et al,. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion 2008; 77: 57-64.
42. Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F,. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol 2010; 105: 2195-201.
43. Silkoff K, Hallak A, Yegena L, et al,. Consumption of refined carbohydrate by patients with Crohn's disease in Tel-Aviv-Yafo. Postgrad Med J 1980; 56: 842-6.
44. Thornton JR, Emmett PM, Heaton KW,. Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J 1979; 2: 762-4.
45. Thornton JR, Emmett PM, Heaton KW,. Diet and ulcerative colitis. Br Med J 1980; 280: 293-4.
46. Thornton JR, Emmett PM, Heaton KW,. Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed) 1985; 290: 1786-7.
47. Tjonneland A, Overvad K, Bergmann MM, et al,. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009; 58: 1606-11.
48. Tragnone A, Valpiani D, Miglio F, et al,. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 47-51.
49. John S, Luben R, Shrestha SS, Welch A, Khaw KT, Hart AR,. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol 2010; 22: 602-6.
50. Amre DK, D'Souza S, Morgan K, et al,. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007; 102: 2016-25.
51. Hansen TS, Jess T, Vind I, et al,. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis 2011; 5: 577-84.
52. Kasper H, Sommer H,. Dietary fiber and nutrient intake in Crohn's disease. Am J Clin Nutr 1979; 32: 1898-901.
53. Persson PG, Ahlbom A, Hellers G,. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992; 3: 47-52.
54. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T,. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997; 40: 754-60.
55. Sakamoto N, Kono S, Wakai K, et al,. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005; 11: 154-63.
56. Ferreira P, Cravo M, Guerreiro CS, Tavares L, Santos PM, Brito M,. Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn's disease activity. Clin Nutr 2010; 29: 819-23.
57. Guerreiro CS, Ferreira P, Tavares L, et al,. Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease. Am J Gastroenterol 2009; 104: 2241-9.
58. Jowett SL, Seal CJ, Pearce MS, et al,. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004; 53: 1479-84.
59. Magee EA, Edmond LM, Tasker SM, Kong SC, Curno R, Cummings JH,. Associations between diet and disease activity in ulcerative colitis patients using a novel method of data analysis. Nutr J 2005; 4: 7.
60. Tanaka M, Iwao Y, Sasaki S, et al,. Moderate dietary temperance effectively prevents relapse of Crohn disease: a prospective study of patients in remission. Gastroenterol Nurs 2007; 30: 202-10.
61. Cohen AB, Lee D, Long MD, et al,. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci 2013; 58: 1322-8.
62. Ripoli J, Miszputen SJ, Ambrogini O Jr, Carvalho L,. Nutritional follow-up of patients with ulcerative colitis during periods of intestinal inflammatory activity and remission. Arq Gastroenterol 2010; 47: 49-55.
63. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ,. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 1998; 67: 919-26.
64. Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E,. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. Br Med J (Clin Res Ed) 1987; 295: 517-20.
65. Riordan AM, Hunter JO, Cowan RE, et al,. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 1993; 342: 1131-4.
66. Lorenz-Meyer H, Bauer P, Nicolay C, et al,. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). Scand J Gastroenterol 1996; 31: 778-85.
67. Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR,. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis 2009; 3: 8-14.
68. Akobeng AK, Thomas AG,. Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2007; 3: CD005984.
69. Zachos M, Tondeur M, Griffiths AM,. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007; 1: CD000542.
70. De Ley M, de Vos R, Hommes DW, Stokkers P,. Fish oil for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; 4: CD005986.
71. Hu FB,. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 2002; 13: 3-9.
72. Schaible TD, Harris RA, Dowd SE, Smith CW, Kellermayer R,. Maternal methyl-donor supplementation induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes. Hum Mol Genet 2011; 20: 1687-96.
73. Devkota S, Wang Y, Musch MW, et al,. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012; 487: 104-8.
74. Zimmer J, Lange B, Frick JS, et al,. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 2012; 66: 53-60.
75. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P,. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114: 262-7.
76. Khan KJ, Ullman TA, Ford AC, et al,. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011; 106: 661-73.
77. Sepehri S, Kotlowski R, Bernstein CN, Krause DO,. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 675-83.
78. Walker AW, Sanderson JD, Churcher C, et al,. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 2011; 11: 11-7.
79. Jonkers D, Penders J, Masclee A, Pierik M,. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs 2012; 72: 803-23.